Ziopharm Oncology reported $982K in Trade Creditors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US $ 1277M 119M
Arena Pharmaceuticals ARNA:US $ 3.78M 5.76M
Baxter International BAX:US 1.01B 18M
Biogen BIIB:US $ 375.3M 55.1M
Bristol Myers Squibb BMY:US $ 3609M 637M
Corcept Therapeutics CORT:US $ 9.22M 2.25M
Curis CRIS:US $ 4.05M 0.62M
Eleven Biotherapeutics EBIO:US 1.23M 776K
Immunogen IMGN:US $ 11.63M 1.28M
Intercept Pharmaceuticals ICPT:US $ 15.09M 2.51M
Intrexon XON:US $ 4.94M 0.64M
Karyopharm Therapeutics KPTI:US $ 2.31M 731K
Novartis NOVN:VX 4.81B 229M
Ptc Therapeutics PTCT:US $ 20.82M 1.71M
Regeneron Pharmaceuticals REGN:US $ 476M 66.9M
Sangamo Biosciences SGMO:US 10.13M 1.51M
Verastem VSTM:US $ 1.4M 1.06M
YTE INCY:US $ 122.1M 37.04M
Ziopharm Oncology ZIOP:US $ 982K 3.21M